Bank of New York Mellon’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.38M | Buy |
699,913
+7,511
| +1% | +$25.5K | ﹤0.01% | 2648 |
|
|
2025
Q1 | $2.78M | Sell |
692,402
-38,307
| -5% | -$154K | ﹤0.01% | 2511 |
|
|
2024
Q4 | $4.74M | Buy |
730,709
+11,665
| +2% | +$75.7K | ﹤0.01% | 2315 |
|
|
2024
Q3 | $3.98M | Sell |
719,044
-85,217
| -11% | -$472K | ﹤0.01% | 2402 |
|
|
2024
Q2 | $4.49M | Buy |
804,261
+29,579
| +4% | +$165K | ﹤0.01% | 2387 |
|
|
2024
Q1 | $5.2M | Sell |
774,682
-43,588
| -5% | -$292K | ﹤0.01% | 2311 |
|
|
2023
Q4 | $7.46M | Sell |
818,270
-7,310
| -0.9% | -$66.7K | ﹤0.01% | 2158 |
|
|
2023
Q3 | $4.56M | Buy |
825,580
+65,551
| +9% | +$362K | ﹤0.01% | 2362 |
|
|
2023
Q2 | $6.49M | Buy |
760,029
+369,488
| +95% | +$3.16M | ﹤0.01% | 2177 |
|
|
2023
Q1 | $3.59M | Sell |
390,541
-6,495
| -2% | -$59.7K | ﹤0.01% | 2479 |
|
|
2022
Q4 | $4.05M | Buy |
397,036
+3,002
| +0.8% | +$30.7K | ﹤0.01% | 2455 |
|
|
2022
Q3 | $5.8M | Buy |
394,034
+66,045
| +20% | +$972K | ﹤0.01% | 2218 |
|
|
2022
Q2 | $3.52M | Buy |
327,989
+61,654
| +23% | +$662K | ﹤0.01% | 2510 |
|
|
2022
Q1 | $2.87M | Buy |
266,335
+213,476
| +404% | +$2.3M | ﹤0.01% | 2729 |
|
|
2021
Q4 | $863K | Buy |
52,859
+14,290
| +37% | +$233K | ﹤0.01% | 3468 |
|
|
2021
Q3 | $826K | Buy |
+38,569
| New | +$826K | ﹤0.01% | 3506 |
|